ABCs Report: Streptococcus pneumoniae, 2017

April 5, 2019: Content on this page kept for historical reasons.

Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network

Print-friendly version of this surveillance report Cdc-pdf[1 page]

Surveillance Note

 Missing race (n=301) data were multiply imputed using sequential regression imputation methods.

ABCs Areas

California (3 county San Francisco Bay area); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New Mexico; New York (15 county Rochester and Albany areas and children <5 years in Erie county); Oregon (3 county Portland area); Tennessee (20 counties).

ABCs Population

The surveillance areas represent 34,293,143 persons.

Source: National Center for Health Statistics bridged race vintage 2017 postcensal file

ABCs Case Definition

Invasive pneumococcal disease: isolation of Streptococcus pneumoniae from normally sterile site in resident of a surveillance area in 2017.

ABCs Methodology

ABCs personnel routinely contacted all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that include information on demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. WGS based characterization was conducted on all pneumococcal isolates, which includes deduction of capsular serotype and MIC predictions (including PBP typing system for determining beta lactam antibiotic MICs). Conventional MIC testing is conducted on selected strains. Regular laboratory audits assessed completeness of active surveillance and detected additional cases.

Rates of invasive pneumococcal disease were calculated using population estimates for 2017 from the bridged-race vintage 2017 postcensal file. For national estimates, race and age specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 2017 U.S. population. Cases with missing data, excluding ethnicity, were multiply imputed using sequential regression imputation methods.

Reported ABCs Profiles

Race No. (Rate*)
White 2,234 (8.8)
Black 798 (13.9)
Other 223 (6.8)

* Per 100,000 population for ABCs areas

Age (years) Cases
No. (Rate*)
Deaths
No. (Rate*)
< 1 48 (11.6) 3 (0.72)
1 33 (7.9) 2 (0.48)
2-4 66 (5.2) 4 (0.32)
5-17 86 (1.5) 6 (0.11)
18-34 203 (2.5) 14 (0.17)
35-49 411 (6.1) 30 (0.44)
50 64 1,116 (16.6) 125 (1.86)
65-74 618 (20.8) 82 (2.76)
75-84 407 (29.3) 44 (3.16)
≥ 85 267 (41.8) 61 (9.56)
Total  3,255 (9.5) 371 (1.08)

* Per 100,000 population for ABCs areas

Syndrome No. (%*)
Meningitis 226 (6.9)
Bacteremia without focus 533 (16.4)
Pneumonia with bacteremia 2,254 (69.3)

* Percent of cases

 

Antibiotic
Susceptibility
S* I R
Penicillin+ 96.0 1.7 2.4
Cefotaxime 97.9 1.8 0.3
Erythromycin 70.7 0.0 29.3
TMP/Sulfa 82.0 11.1 6.9
Tetracycline 88.7 0.0 11.3
Levofloxacin 99.9 0.0 0.1
Vancomycin 100 0.0 0.0

Based on reference lab testing of 2,897 isolates
* Susceptible; Intermediate; Resistant based on year 2017 CLSI definitions
+ Penicillin CLSI breakpoints changed in 2009

National Estimates of Invasive Disease

Cases: 31,000 (9.5/100,000)
Deaths: 3,590 (1.10/100,000)

Healthy People 2020 Update

Objective: Decrease the incidence of invasive pneumococcal infections to 12 per 100,000 persons less than 5 years of age and to 31 per 100,000 persons aged 65 and older.

Age (year) 2020 Objective 2017  Rate*
< 5 12/100,000 7/100,000
≥ 65 31/100,000 26/100,000

* Per 100,000 U.S. population < 5 years or ≥ 65 years

Citation

Centers for Disease Control and Prevention. 2017. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2017.

 Top of Page

View Page In:Cdc-pdf
Page last reviewed: April 5, 2019 (archived document)